Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Intuitive Machines (LUNR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Intuitive Machines — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Intuitive Machines trades at $10.67 (market cap $1.97B). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 4.3× Intuitive Machines's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Intuitive Machines nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Intuitive Machines for 7 Days on average.
| HNGE | LUNR | |
|---|---|---|
Market Cap | $8.48B | $1.97B |
Volume | 879,799 | 6,024,737 |
Sector | Health | Industrials |
52-Week High | $105.14 | $45.70 |
52-Week Low | $31.17 | $8.05 |
Typical Hold Time | 0 Days | 7 Days |
Enterprise Value | $8.10B | $2.04B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Intuitive Machines (LUNR) trades at $12.18, down 5.29% on the day, reflecting a bearish technical trend. The company is in a high-growth phase, with revenue projected to surge from $207 million in 2025 to $481 million in 2026, but it remains deeply unprofitable with a net loss margin of -27.1%. Recent news highlights its strategic position in lunar infrastructure and satellite manufacturing, supported by NASA contracts, though the stock faces pressure from broader sector weakness.
The investment case hinges on execution of its growth strategy amid significant cash burn. Analyst consensus is strongly bullish with an $31.33 price target, but high execution risk and persistent losses present a speculative opportunity. Key risks include dependence on government contracts and intense competition in the space sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Intuitive Machines
Intuitive Machines provides lunar access, data, and infrastructure services. Its capabilities include lunar landers, communications systems, and technologies designed to support missions to the Moon.
Read more on LUNR →
